Cath Eberlein

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Radical Prostatectomy

Extracellular Matrix

Top Venues

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Shauna McClelland, Pamela J Maxwell, Cristina M Branco, Simon T Barry, Cath Eberlein, Melissa J LaBonte
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance. Cancers 16 (16) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Shauna McClelland, Pamela J Maxwell, Cristina M Branco, Simon T Barry, Cath Eberlein, Melissa J LaBonte
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance. Cancers 16 (16) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)